• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholding Pattern
    • Shareholder Information
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Compliance

Compliance

Closure of Trading Window

Shareholding Pattern

Statement of Investor Complaint

Corporate Governance Report

Statement of Reconciliation of Share Capital Audit Report

A statement under Regulation 74(5

Details of the Familiarization Programme Imparted to Independent Director (ID)

Details of the Familiarization Programme Imparted to Independent Director (ID)

Copyrights Reserved 2008-2022. Naxpar Group
en English
en Englishfr Frenchru Russianes Spanish